C-type lectins facilitate tumor metastasis (Review)

Oncology Letters

Volumn 13, Issue 1, 2017, Pages 13-21

  Ding, Dongbing ^a   Yao, Yao ^b   Zhang, Songbai ^a   Su, Chunjie ^a   Zhang, Yonglian ^a  

^a Jingmen First People s Hospital   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

C type lectins; Lectin; Metastasis; Tumor

Indexed keywords

ADDRESSIN; DECTIN 1; MANNOSE RECEPTOR; MATRIX METALLOPROTEINASE 14; OLIGONUCLEOTIDE; PADGEM PROTEIN; SELECTIN; SMALL INTERFERING RNA;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; HUMAN; IMMUNE RESPONSE; IMMUNITY; INFLAMMATION; LYMPH NODE METASTASIS; METASTASIS; NATURAL KILLER T CELL; PROTEIN DEGRADATION; REVIEW; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; TUMOR MODEL;

EID: 85004028955     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2016.5431     Document Type: Review

References (91)

1. Chaffer CL and Weinberg RA: A perspective on cancer cell metastasis. Science 331: 1559-1564, 2011.
2. Chambers AF, Groom AC and MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2: 563-572, 2002.
3. Alitalo K, Tammela T and Petrova TV: Lymphangiogenesis in development and human disease. Nature 438: 946-953, 2005.
4. Fidler IJ: The pathogenesis of cancer metastasis: The ‘seed and soil’ hypothesis revisited. Nat Rev Cancer 3: 453-458, 2003.
5. Läubli H and Borsig L: Selectins promote tumor metastasis. Semin Cancer Biol 20: 169-177, 2010.
6. Arabzadeh A, Chan C, Nouvion AL, Breton V, Benlolo S, DeMarte L, Turbide C, Brodt P, Ferri L and Beauchemin N: Host-related carcinoembryonic antigen cell adhesion molecule 1 promotes metastasis of colorectal cancer. Oncogene 32: 849-860, 2013.
7. Desgrosellier JS and Cheresh DA: Integrins in cancer: Biological implications and therapeutic opportunities. Nat Rev Cancer 10: 9-22, 2010.
8. van Gisbergen KP, Aarnoudse CA, Meijer GA, Geijtenbeek TB and van Kooyk Y: Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin. Cancer Res 65: 5935-5944, 2005.
9. Jiang Y, Zhang C, Chen K, Chen Z, Sun Z, Zhang Z, Ding D, Ren S and Zuo Y: The clinical significance of DC-SIGN and DC-SIGNR, which are novel markers expressed in human colon cancer. PLoS One 9: e114748, 2014.
10. Zuo Y, Ren S, Wang M, Liu B, Yang J, Kuai X, Lin C, Zhao D, Tang L and He F: Novel roles of liver sinusoidal endothelial cell lectin in colon carcinoma cell adhesion, migration and in vivo metastasis to the liver. Gut 62: 1169-1178, 2013.
11. Kannagi R, Izawa M, Koike T, Miyazaki K and Kimura N: Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci 95: 377-384, 2004.
12. Feinberg H, Mitchell DA, Drickamer K and Weis WI: Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR. Science 294: 2163-2166, 2001.
13. Kansas GS: Selectins and their ligands: Current concepts and controversies. Blood 88: 3259-3287, 1996.
14. Martinez-Pomares L: The mannose receptor. J Leukoc Biol 92: 1177-1186, 2012.
15. Mitchell DA, Fadden AJ and Drickamer K: A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands. J Biol Chem 276: 28939-28945, 2001.
16. Zarbock A, Ley K, McEver RP and Hidalgo A: Leukocyte ligands for endothelial selectins: Specialized glycoconjugates that mediate rolling and signaling under flow. Blood 118: 6743-6751, 2011.
17. Pals ST, de Gorter DJ and Spaargaren M: Lymphoma dissemination: The other face of lymphocyte homing. Blood 110: 3102-3111, 2007.
18. Qian F, Hanahan D and Weissman IL: L-selectin can facilitate metastasis to lymph nodes in a transgenic mouse model of carcinogenesis. Proc Natl Acad Sci USA 98: 3976-3981, 2001.
19. Sperandio M: Selectins and glycosyltransferases in leukocyte rolling in vivo. FEBS J 273: 4377-4389, 2006.
20. Girard JP, Moussion C and Förster R: HEV, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat Rev Immunol 12: 762-773, 2012.
21. Irjala H, Johansson EL, Grenman R, Alanen K, Salmi M and Jalkanen S: Mannose receptor is a novel ligand for L-selectin and mediates lymphocyte binding to lymphatic endothelium. J Exp Med 194: 1033-1042, 2001.
22. Zuo Y, Wei W, Liu C, Zhao L, Wang L and Zhang J: Silencing L-selectin expression by siRNA attenuated metastasis of murine lymphoid neoplasm cell P388D1 to peripheral lymph nodes. Leukemia 21: 180-183, 2007.
23. Wei W, Zuo Y, Hu Y, Wang L, Jia L and Zhang J: Heparin inhibits P388D1 cells adherence and metastasis to peripheral lymph nodes in vitro and in vivo. Lymphology 42: 10-18, 2009.
24. Aviram R, Raz N, Kukulansky T and Hollander N: Expression of L-selectin and efficient binding to high endothelial venules do not modulate the dissemination potential of murine B-cell lymphoma. Cancer Immunol Immunother 50: 61-68, 2001.
25. Wei J, Cui L, Liu F, Fan Y, Lang R, Gu F, Guo X, Tang P and Fu L: E-selectin and Sialyl Lewis X expression is associated with lymph node metastasis of invasive micropapillary carcinoma of the breast. Int J Surg Pathol 18: 193-200, 2010.
26. Gay LJ and Felding-Habermann B: Contribution of platelets to tumour metastasis. Nat Rev Cancer 11: 123-134, 2011.
27. Gout S, Tremblay PL and Huot J: Selectins and selectin ligands in extravasation of cancer cells and organs electivity of metastasis. Clin Exp Metastasis 25: 335-344, 2008.
28. Tomlinson J, Wang JL, Barsky SH, Lee MC, Bischoff J and Nguyen M: Human colon cancer cells express multiple glycoprotein ligands for E-selecin. Int J Oncol 16: 347-353, 2000.
29. Khatib AM, Fallavollita L, Wancewicz EV, Monia BP and Brodt P: Inhibition of hepatic endothelial E-selectin expression by C-raf antisense oligonucleotides blocks colorectal carcinoma liver metastasis. Cancer Res 62: 5393-5398, 2002.
30. Khatib AM, Kontogiannea M, Fallavollita L, Jamison B, Meterissian S and Brodt P: Rapid induction of cytokine and E-selectin expression in the liver in response to metastatic tumor cells. Cancer Res 59: 1356-1361, 1999.
31. Hanley WD, Burdick MM, Konstantopoulos K and Sackstein R: CD44 on LS174T colon carcinoma cells possesses E-selectin ligand activity. Cancer Res 65: 5812-5817, 2005.
32. Burdick MM, Chu JT, Godar S and Sackstein R: HCELL is the major E-and L-selectin ligand expressed on LS174T colon carcinoma cells. J Biol Chem 281: 13899-13905, 2006.
33. Brodt P, Fallavollita L, Bresalier RS, Meterissian S, Norton CR and Wolitzky BA: Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis. Int J Cancer 71: 612-619, 1997.
34. Köhler S, Ullrich S, Richter U and Schumacher U: E-/P-selectins and colon carcinoma metastasis: First in vivo evidence for their crucial role in a clinically relevant model of spontaneous metastasis formation in the lung. Br J Cancer 102: 602-609, 2010.
35. Zen K, Liu DQ, Guo YL, Wang C, Shan J, Fang M, Zhang CY and Liu Y: CD44v4 is a major E-selectin ligand that mediates breast cancer cell transendothelial migration. PLoS One 3: e1826, 2008.
36. Shirure VS, Henson KA, Schnaar RL, Nimrichter L and Burdick MM: Gangliosiedes expressed on breast cancer cells are E-selectin ligands. Biochem Biophys Res Commun 406: 423-429, 2011.
37. Shirure VS, Reynolds NM and Burdick MM: Mac-2 binding protein is a novel E-selectin ligand expressed by breast cancer cell. PLoS One 7: e44529, 2012.
38. Dimitroff CJ, Lechpammer M, Long-Woodward D and Kutok JL: Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin. Cancer Res 64: 5261-5269, 2004.
39. Yoshimoto K, Tajima H, Ohta T, Okamoto K, Sakai S, Kinoshita J, Furukawa H, Makino I, Hayashi H, Nakamura K, et al: Increased E-selectin in hepatic ischemia-reperfusion injury mediates liver metastasis of pancreatic cancer. Oncol Rep 28: 791-796, 2012.
40. Kobayashi K, Matsumoto S, Morishima T, Kawabe T and Okamoto T: Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking E-selectin expression. Cancer Res 60: 3978-3984, 2000.
41. Raes G, Ghassabeh GH, Brys L, Mpofu N, Verschueren H, Vanhecke D and De Baetselier P: The metastatic T-cell hybridoma antigen/P-selectin glycoprotein ligand 1 is required for hematogenous metastasis of lymphomas. Int J Cancer 121: 2646-2652, 2007.
42. Aigner S, Sthoeger ZM, Fogel M, Weber E, Zarn J, Ruppert M, Zeller Y, Vestweber D, Stahel R, Sammar M and Altevogt P: CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood 89: 3385-3395, 1997.
43. Alves CS, Burdick MM, Thomas SN, Pawar P and Konstantopoulos K: The dual role of CD44 as a functional P selectin ligand and fibrin receptor in colon carcinoma cell adhesion. Am J Physiol Cell Physiol 294: C907-C916, 2008.
44. Garcia J, Callewaert N and Borsig L: P-selectin mediates metastatic progression through binding to sulfatides on tumor cells. Glycobiology 17: 185-196, 2007.
45. Monzavi-Karbassi B, Stanley JS, Hennings L, Jousheghany F, Artaud C, Shaaf S and Kieber-Emmons T: Chondroitin sulfate glycosaminoglycans as major P-selectin ligands on metastatic breast cancer cell lines. Int J Cancer 120: 1179-1191, 2007.
46. Stone JP and Wagner DD: P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer. J Clin Invest 92: 804-813, 1993.
47. Ludwig RJ, Boehme B, Podda M, Henschler R, Jager E, Tandi C, Boehncke WH, Zollner TM, Kaufmann R and Gille J: Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis. Cancer Res 64: 2743-2750, 2004.
48. Kim YJ, Borsig L, Varki NM and Varki A: P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci USA 95: 9325-9330, 1998.
49. Chen JL, Chen WX, Zhu JS, Chen NW, Zhou T, Yao M, Zhang DQ and Wu YL: Effect of P-selectin monoclonal antibody on metastasis of gastric cancer and immune function. World J Gastroenterol 9: 1607-1610, 2003.
50. Wei M, Tai G, Gao Y, Li N, Huang B, Zhou Y, Hao S and Zeng X: Modified heparin inhibits P-selectin-mediated cell adhesion of human colon carcinoma cells to immobilized platelets under dynamic flow conditions. J Biol Chem 279: 29202-29210, 2004.
51. Gao Y, Wei M, Zheng S, Ba X, Hao S and Zeng X: Chemically modified heparin inhibits the in vitro adhesion of nonsmall cell lung cancer cells to P-selectin. J Cancer Res Clin Oncol 132: 257-264, 2006.
52. Borsig L, Vlodavsky I, Ishai-Michaeli R, Torri G and Vismara E: Sulfated hexasaccharides attenuate metastasis by inhibition of P-selectin and heparanase. Neoplasia 13: 445-452, 2011.
53. Sperandio M, Smith ML, Forlow SB, Olson TS, Xia L, McEver RP and Ley K: P-selectin glycoprotein ligand-1 mediates L-selectin dependent leukocyte rolling in venules. J Exp Med 197: 1355-1363, 2003.
54. Läubli H, Stevenson JL, Varki A, Varki NM and Borsig L: L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest. Cancer Res 66: 1536-1542, 2006.
55. Borsig L, Wong R, Hynes RO, Varki NM and Varki A: Synergistic effects of L-and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc Natl Acad Sci USA 99: 2193-2198, 2002.
56. Dallas MR, Chen SH, Streppel MM, Sharma S, Maitra A and Konstantopoulos K: Sialofucosylated podocalyxin is a functional E-and L-selectin ligand expressed by metastatic pancreatic cancer cells. Am J Physiol Cell Physiol 303: C616-C624, 2012.
57. Hanley WD, Napier SL, Burdick MM, Schnaar RL, Sackstein R and Konstantopoulos K: Variant isoforms of CD44 are P-and L-selectin ligands on colon carcinoma cells. FASEB J 20: 337-339, 2006.
58. Thomas SN, Zhu F, Schnaar RL, Alves CS and Konstantopoulos K: Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E-and L-selectin in shear flow. J Biol Chem 283: 15647-15655, 2008.
59. Rivera-Calzada A, Robertson D, MacFadyen JR, Boskovic J, Isacke CM and Llorca O: Three-dimensional interplay among the ligand-binding domains of the urokinase-plasminogen-activator-receptor-associated protein, Endo180. EMBO Rep 4: 807-812, 2003.
60. Jürgensen HJ, Madsen DH, Ingvarsen S, Melander MC, Gårdsvoll H, Patthy L, Engelholm LH and Behrendt N: A novel functional role of collagen glycosylation: Interaction with the endocytic receptor uPARAP/Endo180. J Biol Chem 286: 32736-32748, 2011.
61. Irjala H, Alanen K, Grénman R, Heikkilä P, Joensuu H and Jalkanen S: Mannose receptor (MR) and common lymphatic endothelial and vascular endothelial receptor (CLEVER)-1 direct the binding of cancer cells to the lymph vessel endothelium. Cancer Res 63: 4671-4676, 2003.
62. Marttila-Ichihara F, Turja R, Miiluniemi M, Karikoski M, Maksimow M, Niemelä J, Martinez-Pomares L, Salmi M and Jalkanen S: Macrophage mannose receptor on lymphatics controls cell trafficking. Blood 112: 64-72. 2008.
63. Salmi M, Karikoski M, Elima K, Rantakari P and Jalkanen S: CD44 binds to macrophage mannose receptor on lymphatic endothelium and supports lymphocyte migration via afferent lymphatics. Circ Res 112: 1577-1582, 2013.
64. Götte M and Yip GW: Heparanase, hyaluronan, and CD44 in cancers: A breast carcinoma perspective. Cancer Res 66: 10233-10237, 2006.
65. Wielenga VJ, van der Neut R, Offerhaus GJ and Pals ST: CD44 glycoproteins in colorectal cancer: Expression, function, and prognostic value. Adv Cancer Res 77: 169-187, 2000.
66. Leung EL, Fiscus RR, Tung JW, Tin VP, Cheng LC, Sihoe AD, Fink LM, Ma Y and Wong MP: Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties. PLoS One 5: e14062, 2010.
67. Jürgensen HJ, Madsen DH, Ingvarsen S, Melander MC, Gårdsvoll H, Patthy L, Engelholm LH and Behrendt N: A novel functional role of collagen glycosylation: Interraction with the endocytic collagen receptor uPARAP/ENDO180. J Biol Chem 286: 32736-32748, 2011.
68. Kogianni G, Walker MM, Waxman J and Sturge J: Endo180 expression with cofunctional partners MT1-MMP and uPAR-uPA is correlated with prostate cancer progression. Eur J Cancer 45: 685-693, 2009.
69. Sulek J, Wagenaar-Miller RA, Shireman J, Molinolo A, Madsen DH, Engelholm LH, Behrendt N and Bugge TH: Increased expression of the collagen internalization receptor uPARAP/Endo180 in the stroma of head and neck cancer. J Histochem Cytochem 55: 347-353, 2007.
70. Wienke D, Davies GC, Johnson DA, Sturge J, Lambros MB, Savage K, Elsheikh SE, Green AR, Ellis IO, Robertson D, et al: The collagen receptor Endo180 (CD280) is expressed on basal-like breast tumor cells and promotes tumor growth in vivo. Cancer Res 67: 10230-10240, 2007.
71. Huijbers IJ, Iravani M, Popov S, Robertson D, Al-Sarraj S, Jones C and Isacke CM: A role for fibrillar collagen deposition and the collagen internalization receptor endo180 in glioma invasion. PLoS One 5: e9808, 2010.
72. Engelholm LH, Ingvarsen S, Jürgensen HJ, Hillig T, Madsen DH, Nielsen BS and Behrendt N: The collagen receptor uPARAP/Endo180. Front Biosci (Landmark Ed) 14: 2103-2114, 2009.
73. Curino AC, Engelholm LH, Yamada SS, Holmbeck K, Lund LR, Molinolo AA, Behrendt N, Nielsen BS and Bugge TH: Intracelluar collagen degradation mediated by uPARAP/Endo180 is a major pathway of extracellular matrix turnover during malignancy. J Cell Biol 169: 977-985, 2005.
74. Palmieri C, Caley MP, Purshouse K, Fonseca AV, Rodriguez-Teja M, Kogianni G, Woodley L, Odendaal J, Elliott K, Waxman J and Sturge J: Endo180 modulation by bisphosphonates and diagnostic accuracy in metastatic breast cancer. Br J Cancer 108: 163-169, 2013.
75. Takahashi S, Yamada-Okabe H, Hamada K, Ohta S, Kawase T, Yoshida K and Toda M: Downregulation of uPARAP mediates cytoskeletal rearrangements and decreases invasion and migration properties in glioma cells. J Neurooncol 103: 267-276, 2011.
76. George JN: Platelets. Lancet 355: 1531-1539, 2000.
77. Takagi S, Sato S, Oh-hara T, Takami M, Koike S, Mishima Y, Hatake K and Fujita N: Platelets promote tumor growth and metastasis via direct interaction between Aggrus/podoplanin and CLEC-2. PLoS One 8: e73609, 2013.
78. Lowe KL, Finney BA, Deppermann C, Hägerling R, Gazit SL, Frampton J, Buckley C, Camerer E, Nieswandt B, Kiefer F and Watson SP: Podoplanin and CLEC-2 drive cerebrovascular patterning and integrity during development. Blood 125: 3769-3777, 2015.
79. Lowe KL, Navarro-Nunez L and Watson SP: Platelet CLEC-2 and podoplanin in cancer metastasis. Thromb Res 129 (Suppl 1): S30-S37, 2012.
80. Martín-Villar E, Scholl FG, Gamallo C, Yurrita MM, Muñoz-Guerra M, Cruces J and Quintanilla M: Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas. Int J Cancer 113: 899-910, 2005.
81. Rodrigo JP, Garcia-Carracedo D, González MV, Mancebo G, Fresno MF and García-Pedrero J: Podoplanin expression in the development and progression of laryngeal squamous cell carcinomas. Mol Cancer 9: 48, 2010.
82. Kato Y, Kaneko M, Sata M, Fujita N, Tsuruo T and Osawa M: Enhanced expression of Aggrus (T1alpha/podoplanin), a platelet-aggregation-inducing factor in lung squamous cell carcinoma. Tumour Biol 26: 195-200, 2005.
83. Kimura N and Kimura I: Podoplanin as a marker for mesothelioma. Pathol Int 55: 83-86, 2005.
84. Kato Y, Fujita N, Kunita A, Sato S, Kaneko M, Osawa M and Tsuruo T: Molecular identification of Aggrus/T1alpha as a platelet aggregation-inducing factor expressed in colorectal tumors. J Biol Chem 278: 51599-51605, 2003.
85. Mishima K, Kato Y, Kaneko MK, Nishikawa R, Hirose T and Matsutani M: Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression. Acta Neuropathol 111: 483-488, 2006.
86. Liang M, Zhang P and Fu J: Up-regulation of LOX-1 expression by TNF-alpha promotes trans-endothelial migration of MDA-MB-231 breast cancer cells. Cancer Letters 258: 31-37, 2007.
87. Zhang F, Ren S and Zuo Y: DC-SIGN, DC-SIGNR and LSECtin: C-Type Lectins for Infection. Int Rev Immunol 33: 54-66, 2014.
88. Nonaka M, Ma BY, Murai R, Nakamura N, Baba M, Kawasaki N, Hodohara K, Asano S and Kawasaki T: Glycosylation-dependent interactions of C-type lectin DC-SIGN with colorectal tumor-associated Lewis glycans impair the function and differentiation of monocyte-derived dendritic cells. J Immunol 180: 3347-3356, 2008.
89. Xu F, Liu J, Liu D, Liu B, Wang M, Hu Z, Du X, Tang L and He F: LSECtin expressed on melanoma cells promotes tumor progression by inhibiting antitumor T-cell responses. Cancer Res 74: 3418-3428, 2014.
90. Zhang Z, Chen K, Yan L, Yang Z, Zhu Z, Chen C, Zeng J, Wei W, Qi X, Ren S and Zuo Y: Low expression of dendritic cell-specific intercellular adhesion molecule-grabbing nonintegrin-related protein in non-Hodgkin lymphoma and significant correlations with lactic acid dehydrogenase and β2-microglobulin. Biochem Cell Biol 91: 214-220, 2013.
91. Keler T, Ramakrishna V and Fanger MW: Mannose receptor-targeted vaccines. Expert Opin Biol Ther 4: 1953-1962, 2004.